SCI & TECH● LOWSep 1 · Sep 1, 2026, 6:24 PM
AstraZeneca, Hutchmed succeed in late-stage lung cancer trial for Orpathys, Tagrisso combo
Seeking Alpha Tech · global
AstraZeneca and Hutchmed have announced successful late-stage clinical trial results for a combination therapy involving Orpathys and Tagrisso for lung cancer. This marks a significant advancement in cancer treatment research.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH34m agoJapan launches unprecedented mission to bring back samples from Mars’ moon phobosEuroNews [en]SCI & TECH45m agoJapan launches historic mission to bring back Mars moon samplesAl Jazeera [en]SCI & TECH54m agoChina’s new 0.1-nanometre electron microscope ready to challenge US and JapanSouth China Morning PostSCI & TECH54m agoEmpires of AIForeign Affairs